Dott. Francesco Moro

Ambulatorio di Tricologia con esperienza in diagnosi e trattamenti avanzati di Alopecia androgenetica, Alopecia Areata, Alopecie cicatriziali e genetiche. Laserterapista esperto nell'utilizzo di tutte le tecnologie laser per il trattamento delle patologie cutanee come cicatrici da acne ed angiomi con particolare esperienza in PICOLASER per la rimozione dei tatuaggi. Medicina estetica.

Laurea in Medicina e Chirurgia presso l’Università Cattolica del Sacro Cuore di Roma con votazione di 110/110 Master di II livello in Medicina estetica e terapia presso Università di Camerino e Università di Torino Master di II livello in Scienze Tricologiche presso Università degli studi della Campania "Luigi Vanvitelli" Dottorando di ricerca il dottorato di Biochemstry and Molecular Biology con tematica Malattie Bollose Autoimmuni presso Università degli Studi di Roma Tor Vergata Coordinatore didattico e docente Master II livello in "Medicina Estetica" e " Dermatologia Clinica Avanzata".

• 2017 Laurea in Medicina e Chirurgia presso l’Università Cattolica del Sacro Cuore di Roma

• 2018 Master di II livello in Medicina estetica e terapia presso Università di Camerino & Università di Torino

• 2021 Master di II livello in Scienze Tricologiche presso Università degli studi della Campania “Luigi Vanvitelli”

• 2020-present Dottorando di ricerca il dottorato di Biochemstry and Molecular Biology con tematica Malattie Bollose Autoimmuni presso Università degli Studi di Roma Tor Vergata

• Study Coordinator “Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE)” Sponsor: Amryt Pharma

• 2019-present Docente a contratto e coordinatore didattico master universitario di II livello in Medicina estetica presso Consorzio Humanitas, Roma e Docente master II livello in Dermatologia clinica avanzata

Pubblicazioni

• 2026 Jan 9 - Behavioral sciences (Basel, Switzerland) - Illness Perception, Emotional Distress, and Obsessive-Compulsive Symptomatology in Patients with Alopecia Areata: A Mediation Study.

• 2025 Dec 8 - Biomedicines - Advanced Cutaneous Squamous Cell Carcinoma: Biology, Immunotherapy, and Evolving Prognostic Factors.

• 2025 Dec - Italian journal of dermatology and venereology - Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata.

• 2025 - Computational and structural biotechnology journal - MINN: A metabolic-informed neural network for integrating omics data into genome-scale metabolic modeling.

• 2025 Apr 23 - Life (Basel, Switzerland) - Comprehensive Overview of Cytokine Interplay in Vitiligo: A Decade of Meta-Analyses Systematically Reviewed.

• 2024 Oct 22 - Journal of clinical medicine - Cost-Effectiveness Analysis of Topical Treatments for Actinic Keratosis in Italian National Health System.

• 2024 Sep 5 - Vaccines - COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.

• 2024 - Frontiers in public health - Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.

• 2024 May 11 - Children (Basel, Switzerland) - Ultrasonic Evaluation of the Achilles Tendon in Patients Treated for Congenital Clubfoot: Comparison between Patients Treated with Plaster Alone, Achilles Tenotomy, and Z-Plasty Lengthening.

• 2024 Jun - Journal of the European Academy of Dermatology and Venereology : JEADV - The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience.

• 2023 - Frontiers in medicine - Pemphigus: trigger and predisposing factors.

• 2023 Sep-Oct - Endoscopic ultrasound - Pancreatic leiomyosarcoma: EUS findings of an uncommon pancreatic mass (with video).

• 2023 Dec - Clinical and experimental medicine - Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.

• 2023 - Frontiers in pediatrics - Insulinoma in pediatric tuberous sclerosis complex: a case report.

• 2023 - Frontiers in medicine - Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.

• 2023 - Frontiers in medicine - Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.

• 2022 - Frontiers in medicine - Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis.

• 2022 - Frontiers in medicine - Case report: A rare case of imiquimod-induced atypical pemphigus vulgaris.

• 2022 - Frontiers in medicine - Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.

• 2022 - PloS one - A theoretical analysis of complex armed conflicts.

• 2021 Aug 1 - Dermatology reports - Generalized acquired cutis laxa and urticarial dermatosis associated with k-chain IgA micromolecular myeloma.

• 2021 - Frontiers in immunology - Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab.

• 2021 Feb - The Journal of dermatology - Pemphigus vulgaris in two pairs of siblings from two unrelated Italian families: Human leukocyte antigen genotypes, ST18 mutation and immunological profile.

• 2020 Oct 10 - Biomolecules - Bullous Pemphigoid: Trigger and Predisposing Factors.

• 2020 May - Dermatologic therapy - Successful treatment of Sapho syndrome and hidradenitis suppurativa: A therapeutic challenge.

• 2019 Sep - Dermatologic therapy - A case of miliaris osteoma cutis in a male: Dermoscopic findings and microablation treatment.

• 2018 Oct 1 - European journal of dermatology : EJD - Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy.

• 2020 Oct - Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia - Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients.

• 2014 - International journal of surgery case reports - Left-sided portal hypertension: Successful management by laparoscopic splenectomy following splenic artery embolization.

• 2007 - Cellular & molecular biology letters - Increased expression of HSP70 by colon cancer cells is not always associated with access to the dendritic cell cross-presentation pathway.

• 2003 Nov - Anti-cancer drugs - Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells.